Halemani Kurvatteppa, Dhiraaj Sanjay, Latha Thimmappa, Mishra Prabhakar, Issac Alwin
College of Nursing, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Anesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Clin Epidemiol Glob Health. 2022 Sep-Oct;17:None. doi: 10.1016/j.cegh.2022.101144.
COVID pandemic has massively hit every nook of the world. Millions of people were infected and lost their lives to the deadly pandemic. This novel virus destroyed the essential healthcare service globally. Mass vaccination is the only option to halt the virus transmission. This study aimed to estimate the acceptance of the COVID vaccine among pregnant women and breastfeeding mothers. : We followed Cochrane collaboration guidelines and the PRISMA reporting system. Studies were identified through a systematic search of indexed articles in Medline (PubMed), Clinical key, Google Scholar, Cochrane Library, and CINAHL databases until March 10, 2022, 26,995 articles were identified in the initial search and 24 articles were included in the review. : Twenty four studies comprise 22,947 pregnant and 11,022 breastfeeding women. About 54% of pregnant women and 59% of breastfeeding mothers intended to take the COVID vaccination. Among the pregnant mothers, 21% with comorbidities, 14% in the first trimester, 34% in the second trimester, and 51% in the third trimester were willing to take the COVID vaccine. Risks of infections and comorbidities were the reasons for acceptance of the COVID vaccine in pregnant women. Similarly, adverse effects and safety concerns were top indicators for the rejection of the COVID vaccine. Conclusion: The acceptance of COVID vaccination among pregnant women and breastfeeding mothers are not satisfactory. Therefore, timely guidance would help to address the negative perceptions of vaccines among pregnant women.
新冠疫情席卷全球各个角落。数百万人感染了这种致命的疫情并失去了生命。这种新型病毒破坏了全球基本的医疗服务。大规模接种疫苗是阻止病毒传播的唯一选择。本研究旨在评估孕妇和哺乳期母亲对新冠疫苗的接受程度。：我们遵循了Cochrane协作指南和PRISMA报告系统。通过系统检索Medline（PubMed）、Clinical key、谷歌学术、Cochrane图书馆和CINAHL数据库中索引文章来识别研究，截至2022年3月10日，初始检索中识别出26995篇文章，本综述纳入了24篇文章。：24项研究包括22947名孕妇和11022名哺乳期妇女。约54%的孕妇和59%的哺乳期母亲打算接种新冠疫苗。在孕妇中，21%患有合并症，14%处于孕早期，34%处于孕中期，51%处于孕晚期愿意接种新冠疫苗。感染风险和合并症是孕妇接受新冠疫苗的原因。同样，不良反应和安全担忧是拒绝接种新冠疫苗的首要指标。结论：孕妇和哺乳期母亲对新冠疫苗的接受程度并不理想。因此，及时提供指导将有助于消除孕妇对疫苗的负面看法。
